OverviewSuggest Edit

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and our 11,000 employees manufacture our products in local markets, close to our customers. With over 40 plants in Europe, North America, South America and Asia, we generate revenues of more than EUR 1.4 billion. Our comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
TypePublic
Founded1864
HQDüsseldorf, DE
Websitegerresheimer.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Sept 2020)9,820
Job Openings87
Share Price (Sept 2020)€98.4
Cybersecurity ratingCMore

Key People/Management at Gerresheimer

Dietmar Siemssen

Dietmar Siemssen

CEO
Rainer Beaujean

Rainer Beaujean

CFO
Lukas Burkhardt

Lukas Burkhardt

Primary Packaging Glass Division
Andreas Schutte

Andreas Schutte

Plastics & Devices and Advanced Technologies Divisions
Axel Herberg

Axel Herberg

Chairman of the Supervisory Board
Francesco Grioli

Francesco Grioli

Deputy Chairman of the Supervisory Board
Show more

Gerresheimer Office Locations

Gerresheimer has an office in Düsseldorf
Düsseldorf, DE (HQ)
Klaus-Bungert-Straße 4
Show all (1)

Gerresheimer Financials and Metrics

Gerresheimer Revenue

Market capitalization (18-Sept-2020)

3.1b

Closing stock price (18-Sept-2020)

98.4
Gerresheimer's current market capitalization is €3.1 b.
Show all financial metrics

Gerresheimer Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Gerresheimer Online and Social Media Presence

Embed Graph

Gerresheimer News and Updates

Latin America Injectable Drug Delivery Market Report 2019-2028 Featuring Ypsomed, Sanofi, Gerresheimer, Teva Pharmaceuticals, West Pharmaceuticals, Elcam Medical, Injex, and Schott

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Latin America Injectable Drug Delivery Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The injectable drug delivery market in Latin America has been projected to depict growth in terms of revenue and expand with a CAGR…

PP Plastic Packaging Market Future Outlook - Alpha Packaging, Ontario Plastic Container producers, Cospak, Gepack, Amcor, Berry Global, Gerresheimer, Olcott Plastics, RPC M&H Plastics, All American Containers, Tim Plastics

WiseGuyRerports.com Presents “Global PP Plastic Packaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Pharmaceuticals Packaging 2020 Global Market Key Players – Gerresheimer, Amcor, ACG, Gerresheimer - Analysis and Forecast to 2026

Wiseguyreports.Com Publish New Market Research Report On-“Covid-19 Impact on Pharmaceuticals Packaging Market 2020 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2026” Posted via Industry Today. Follow us on Twitter @IndustryToday

PP Plastic Packaging Market Major Key Players Are Alpha Packaging, Ontario Plastic Container producers, Cospak, Gepack, Amcor, Berry Global, Gerresheimer, Olcott Plastics

wiseguyreports.com Adds “PP Plastic Packaging Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2026” To Its Research Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Gerresheimer With Strong Second Quarter

DUESSELDORF, Germany, July 14, 2020 /PRNewswire/ -- Gerresheimer AG delivered profitable growth in the second quarter of 2020. "As a key supplier to the pharma and healthcare industry, we have significant responsibility for ensuring patients worldwide to receive the medication they need....

Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share

DUESSELDORF, Germany, June 24, 2020 /PRNewswire/ -- Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. "In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and...
Show more

Gerresheimer Frequently Asked Questions

  • When was Gerresheimer founded?

    Gerresheimer was founded in 1864.

  • Who are Gerresheimer key executives?

    Gerresheimer's key executives are Dietmar Siemssen, Rainer Beaujean and Lukas Burkhardt.

  • How many employees does Gerresheimer have?

    Gerresheimer has 9,820 employees.

  • Who are Gerresheimer competitors?

    Competitors of Gerresheimer include SCHOTT, Aptar and Abiomed.

  • Where is Gerresheimer headquarters?

    Gerresheimer headquarters is located at Klaus-Bungert-Straße 4, Düsseldorf.

  • Where are Gerresheimer offices?

    Gerresheimer has an office in Düsseldorf.

  • How many offices does Gerresheimer have?

    Gerresheimer has 1 office.